P1 - Plenary opening symposium: Smart therapeutics

Sorry, Access to this content is only open to registered participants.
If you are not registered yet, click HERE for more information how to register for PSWC2020


Denis DeBlois, Chair of the International Scientific Programme Commitee PSWC


How can we best foster pharmaceutical science innovation and its translation into the clinic?  The current COVID-19 pandemic is an opportunity for pharmaceutical scientists to reflect on the traditional models for drug discovery, development, access and clinical usage to make them more efficient, while maintaining the highest quality. Now more than ever, we need to step up to face global health challenges. This session will bring together a global audience and experts around the theme Smart therapeutics for a complex world.


Welcome address
Giovanni Pauletti, FIP Scientific Secretary, USA
Lyne Lalonde, dean of the Faculty of pharmacy, Université de Montréal

Challenges to therapeutic repurposing and development in a pandemic 
Steven Kern, Bill and Melinda Gates Foundation, USA

How translational sciences are harnessed to face COVID-19
Joni Rutter, NCATS, USA 

Ensuring the global supply of quality medicines: the response to COVID-19
Michael Levy, US Pharmacopeia, USA

The future of drug R&D
Bernard Munos, FasterCure /Milken Institute, USA